ASSERTIO HOLDINGS INC (ASRT)
US04546C2052 - Common Stock
ASSERTIO HOLDINGS INC
NASDAQ:ASRT (12/20/2024, 8:00:01 PM)
Premarket: 0.9 +0.01 (+1.59%)0.8859
+0.04 (+5.09%)
Company Profile
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois and currently employs 53 full-time employees. The firm has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).
Company Info
ASSERTIO HOLDINGS INC
100 S. Saunders Road, Suite 300
Lake Forest ILLINOIS 60045
P: 12244197106
CEO: Daniel A. Peisert
Employees: 53
Website: https://www.assertiotx.com/
ASRT News
6 days ago - Assertio Holdings, Inc.Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of DirectorsLAKE FOREST, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with...
10 days ago - Assertio Holdings, Inc.Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical StudySame-day dosing results comparable to next day dosing schedules...
11 days ago - Assertio Holdings, Inc.Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCOCTO Role to Focus on Growth from New Market and Revenue Strategies...
17 days ago - Beam TherapeuticsBeam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officera month ago - Assertio Holdings, Inc.Assertio Reports Third Quarter 2024 Financial ResultsThird Quarter Total Net Product Sales of $28.7 Million Rolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 Million...
a month ago - Assertio Holdings, Inc.Assertio Provides Response to Letter from Short-sellerClaims about Rolvedon and Assertio’s Accounting Practices are False and Baseless Short-seller’s Press Release is Another Improper Attempt to Enrich...
ASRT Twits
Here you can normally see the latest stock twits on ASRT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
